VSTM
Companies
NASDAQ
Verastem Inc.
Health Care
$5.19
+$0.02 (+0.39%)
Price Chart
Overview
About VSTM
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Market Cap
$86.1M
Volume
4.7M
Avg. Volume
4.7M
P/E Ratio
-1.8359684
Dividend Yield
0.00%
Employees
73.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.30
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, VSTM shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$86.1M
Volume4.7M
P/E Ratio-1.84
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 21, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025